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Baltimore, Maryland; Boston, Massachusetts; Torrance, California; Miami Beach, Florida;
and Nashville, TennesseeOBJECTIVES The aim of this study was to evaluate the impact of coronary artery calcium (CAC)
burden and regional distribution on the need for and type of future coronary revascularizationd
percutaneous versus surgical (coronary artery bypass graft [CABG])damong asymptomatic subjects.
BACKGROUND The need for coronary revascularization and the chosen mode of revascularization
are thought to be functions of disease burden and anatomic distribution. The association between the
baseline burden and regional distribution of CAC and the risk and type of future coronary revasculariza-
tion remains unknown.
METHODS A total of 6,540 participants in the MESA (Multi-Ethnic Study of Atherosclerosis) (subjects
aged 45 to 84 years, free of known baseline cardiovascular disease) with vessel-speciﬁc CAC measure-
ments were followed for a median of 8.5 years (interquartile range: 7.7 to 8.6 years). Annualized rates
and multivariate-adjusted hazard ratios for revascularization and revascularization type were analyzed
according to CAC score category, number of vessels with CAC (0 to 4, including the left main coronary
artery), and involvement of individual coronary arteries.
RESULTS A total of 265 revascularizations (4.2%) occurred during follow-up, and 206 (78% of the total)
were preceded by adjudicated symptoms. Revascularization was uncommon when CAC score was 0.0
(0.6%), with a graded increase over both rising CAC burden and increasingly diffuse CAC distribution.
The revascularization rates per 1,000 person-years for CAC scores of 1 to 100, 101 to 400, and >400 were
4.9, 11.7, and 25.4, respectively; for 1, 2, 3, and 4 vessels with CAC, the rates were 3.0, 8.0, 16.1, and 24.8,
respectively. In multivariatemodels adjusting for CAC score, the number of vessels with CAC remained pre-
dictive of revascularization and mode of revascularization. Independent predictors of CABG versus percu-
taneous coronary intervention included 3- or 4-vessel CAC, higher CAC burden, and involvement of the left
main coronary artery. Risk for CABG was extremely low with <3-vessel baseline CAC. Results were similar
when considering only symptom-driven revascularizations.
CONCLUSIONS In this multiethnic cohort of asymptomatic subjects, baseline CAC was highly
predictive of future coronary revascularization procedures, with measures of CAC burden and distribution
each independently predicting need for percutaneous coronary intervention versus CABG over an
8.5-year follow-up. (J Am Coll Cardiol Img 2014;7:476–86) ª 2014 by the American College of Cardiology
Foundation
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477easurement of the total coronary
artery calcium (CAC) score (Agatston
score) using noncontrast cardiac gated
computed tomography provides an
excellent estimation of cardiovascular risk through
its strong correlation with total coronary athero-
sclerotic burden. Moderate to high CAC is a strong
independent predictor of hard cardiovascular events,
including myocardial infarction and death (1–4). In
contrast, absence of CAC among asymptomatic
patients identiﬁes a low-risk population with <1%
estimated 10-year risk for cardiovascular mortality
(5–7) and a low probability of signiﬁcant coronary
artery disease on invasive coronary angiography
(5). When added to traditional risk prediction
scores, CAC scoring provides signiﬁcant improve-
ment in risk discrimination and risk reclassiﬁcation
across sex and ethnic groups (2,8–10).See page 487
A B B R E V I A T I O N S
A N D A C R O N YM S
CABG = coronary artery bypass
graft
CAC = coronary artery calcium
IQR = interquartile range
PCI = percutaneous coronary
interventionAlthough CAC is a strong marker of future
cardiovascular risk, the extent to which regional
distribution of CAC provides additional risk in-
formation beyond the Agatston score has not been
fully explored. A prior analysis from a registry of
more than 25,000 subjects suggested that left main
or multivessel CAC may identify a higher risk group
independent of the overall CAC score (11). Further
supporting the potential importance of CAC dis-
tribution, there is a signiﬁcant association between
the burden of CAC within an individual coronary
artery and the severity of angiographic stenosis
within the same artery (12).
Revascularization remains an important clinical
endpoint, and the need for and chosen method
of revascularization are directly inﬂuenced by the
overall burden and distribution of angiographic
coronary artery disease. For example, coronary artery
bypass graft (CABG) is commonly associated
with more diffusely distributed angiographic coro-
nary atherosclerosis compared with percutaneous
coronary intervention (PCI). Thus, mode ofFrom the *Johns Hopkins Ciccarone Center for Prevention of Heart Disea
Boston, Massachusetts; zLos Angeles Biomedical Research Institute, Torranc
Baptist Health Medical Group, Miami Beach, Florida; kVanderbilt University
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Manuscript received December 11, 2013; revised manuscript received Marchrevascularization provides an excellent opportunity
to test the importance of the anatomic information
inherent in measures of regional CAC distribution
that is not accounted for in the traditional Agatston
score.
We ﬁrst sought to evaluate whether the distri-
bution of subclinical atherosclerosis, as measured
by CAC, was independently and incrementally
associated with risk for future revascularization.
We then sought to evaluate whether the overall
burden and distribution of CAC was associated
with a speciﬁc mode of revascularization (percuta-
neous vs. surgical), hypothesizing that increasingly
diffuse CAC would be preferentially associated
with future surgical revascularization.
METHODS
Study population. Full details of the MESA
(Multi-Ethnic Study of Atherosclerosis) study
design have been published previously (13).
In brief, MESA is a prospective observational
cohort of 6,814 men and women aged 45
to 84 years from different ethnic origins
(white, black, Hispanic, and Chinese),
with no known baseline clinical cardio-
vascular disease who were asymptomatic at
the time or enrollment. Subjects were
enrolled between July 2000 and September
2002 at 6 ﬁeld centers across the United
States (Baltimore; Chicago; Forsyth
County, North Carolina; Los Angeles;
New York City; and St. Paul, Minnesota). The
study protocol was approved by the institutional
review board at each site, and all participants pro-
vided written informed consent.
Risk factor measurement. As part of the baseline
examination, staff members at each of the 6
centers collected information about cardiovascular
risk factors, including medical history, smoking
history, blood pressure measurement, anthropo-
metric measurements, and laboratory data, as
previously described (13). A central laboratory
(University of Vermont, Burlington, Vermont)se, Baltimore, Maryland; yBrigham and Women’s Hospital,
e, California; xCenter for Prevention and Wellness Research,
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478measured levels of total and high-density lipo-
protein cholesterol, triglycerides, plasma glucose,
and high-sensitivity C-reactive protein after a
12-h fast.
CAC measurement. As previously described by
Carr et al. (14), all MESA study participants un-
derwent measurement of CAC by cardiac com-
puted tomography. Participants were scanned
twice, and CAC was reported as the average
CAC (Agatston) (15) score. Vessel-speciﬁc CAC
measurements were performed in 6,540 MESA
participants (96%). Subjects were told after the
baseline visit (2000 to 2002) whether they had no,
less than average, average, or greater than average
CAC and were encouraged to discuss the results
with their physicians.
Regional CAC was analyzed according to: 1) the
number of vessels with CAC, deﬁned as the number
of main coronary arteries (left main, left anterior
descending, left circumﬂex, and right) with calciﬁ-
cation (values ranging from 0 to 4); and 2) involve-
ment of individual coronary arteries. Three-vessel
CAC was deﬁned as involvement of either the left
main or left anterior descending coronary artery in
addition to CAC in the left circumﬂex and the right
coronary arteries.
Follow-up. Participants were followed for a median
of 8.5 years (interquartile range [IQR]: 7.7 to 8.6
years). At intervals of 9 to 12 months, an interviewer
contacted each participant or family member byFigure 1. Time Elapsed Between MESA Adjudicated MI or Angina a
A majority of all revascularizations occurred within 10 days after adjud
MI ¼ myocardial infarction.telephone to inquire about interim revascularization,
hospital admission, or death. To verify self-reported
diagnoses, MESA obtained medical records for
approximately 98% of hospital events and 95%
of outpatient diagnoses. Two physicians from the
MESA mortality and morbidity review committee
independently classiﬁed events. In the event of
disagreement, the full committee made the ﬁnal
classiﬁcation.
The primary endpoints for this study were time to
ﬁrst revascularization, time to ﬁrst CABG, and time
to ﬁrst PCI. In analyses of mode of revasculariza-
tion, all CABG events were considered. For these
analyses, we excluded PCIs that followed CABG
procedures.
At the time of hospitalization, before the revas-
cularization procedure, individuals were classiﬁed
as having preceding adjudicated myocardial in-
farctions, angina, or neither. The diagnosis of
myocardial infarction was based on a combination
of symptoms, electrocardiographic ﬁndings, and
levels of cardiac biomarkers. A classiﬁcation of
angina required symptoms of chest pain (or other
related symptoms), a physician diagnosis of angina,
and medical treatment for the symptoms. Revas-
cularization or a physician diagnosis of angina or
coronary heart disease without documented symp-
toms was not considered angina.
For sensitivity analyses, “symptom-driven revas-
cularization” was deﬁned as having adjudicatednd Revascularization
icated symptoms. MESA ¼ Multi-Ethnic Study of Atherosclerosis;
Table 1. Baseline Characteristics by Coronary Revascularization Status
No Revascularization
(n [ 6,275 [95.9%])
Revascularization
(n [ 265 [4.1%]) p Value
Age, yrs 62  10 66  9 <0.001
Women 54 24 <0.001
Race/ethnicity <0.001
White 38 52
Black 28 20
Hispanic 23 20
Chinese 12 8
Smoking (current) 13 15 0.004
Pack-years 11  22 17  28 <0.001
Hypertension 44 62 <0.001
Systolic blood pressure, mm Hg 126  21 132  22 <0.001
Diastolic blood pressure, mm Hg 72  10 73  11 0.05
Antihypertensive medication 37 54 <0.001
Diabetes 12 24 <0.001
LDL, mg/dl 117  31 123  35 <0.001
HDL, mg/dl 51  15 45  14 <0.001
Triglycerides, mg/dl 111 (77–159) 123 (90–189) 0.001
Lipid-lowering medication 16 25 <0.001
hsCRP, mg/dl 1.9 (0.8–4.2) 2.0 (1.0–4.7) 0.08
Family history of CHD 42 59 <0.001
Education 0.22
Bachelor’s degree 35 41
No bachelor’s degree 65 59
CAC presence 48 93 <0.001
CAC score, % of total <0.001
0 52 7
1–100 27 24
101–400 13 29
>400 9 40
Agatston score 0 (0–70) 254 (66–741) <0.001
No. of vessels with CAC 1.03  1.3 2.7  1.2 <0.001
Values are mean  SD, %, or median (interquartile range).
CAC ¼ coronary artery calcium; CHD ¼ coronary heart disease; HDL ¼ high-density lipoprotein; hsCRP ¼
high-sensitivity C-reactive protein; LDL ¼ low-density lipoprotein.
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479myocardial infarction or angina within 365 days
before revascularization.
Statistical analysis. The baseline characteristics of
the study population were analyzed according to
revascularization status. Frequencies and pro-
portions were calculated for categorical variables,
and either means with standard deviations or me-
dians with IQRs were calculated for continuous
variables. Differences between the 2 groups were
calculated using chi-square tests, Student t tests, or
nonparametric testing as appropriate.
Kaplan-Meier curves were constructed expressing
time to revascularization as a function of number of
vessels with CAC (0, 1, 2, 3, or 4) and CAC score
groups (0, 1 to 100, 101 to 400, and >400).
To evaluate the predictive value of CAC score
and CAC distribution on the need for subsequent
revascularization and revascularization type, annu-
alized absolute event rates (number of events divided
by number of person-years at risk) were calculated
after stratiﬁcation by CAC distribution (0, 1, 2, 3,
or 4 vessels with CAC) and CAC score category (0,
1 to 100, 101 to 400, or >400). Multivariate-
adjusted Cox proportional-hazards models were
used to calculate hazard ratios and 95% conﬁdence
intervals, with a CAC score of 0 as the reference
group. Models were adjusted for age, sex, race or
ethnicity, smoking, diabetes mellitus, hypertension,
low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol, triglycerides, C-reactive
protein, family history of coronary heart disease,
antihypertensive medication use, lipid-lowering
medication use, education level, and MESA study
site. To test for an additive value of regional mea-
sures of CAC beyond traditional CAC scoring,
additional models were constructed in the subgroup
of participants with CAC scores >0, further
adjusting for the CAC score group.
We then compared speciﬁc CAC characteristics
among those who underwent revascularization, ac-
cording to the chosen mode of revascularization
(PCI vs. CABG). Among the few participants with
baseline CAC scores of 0 who ultimately underwent
revascularization, we produced a descriptive analysis
summarizing the data on demographics, risk factors,
serial CAC scanning, adjudicated symptomatology,
and mode of revascularization.
Sensitivity analyses. Sensitivity analyses were per-
formed excluding subjects who underwent early re-
vascularization within 90 days of CAC scanning (n ¼
2). Among subjects who underwent revascularization,
there was a small number (22% of revascularizations)
without MESA-adjudicated angina or myocardial
infarction within 365 days revascularization. Toconﬁrm that the inclusion of these subjects did not
cause biased results that could be directly attributable to
CAC testing, sensitivity analyses were performed
among only those subjects with MESA-adjudicated
diagnoses of angina or myocardial infarction at hospi-
talization before revascularization.
Additionally, to evaluate whether change in
medication use had an impact on revascularization
rates, sensitivity analysis was performed adjusting
for change in medication (angiotensin-converting
enzyme inhibitors, angiotensin receptor blockers,
Figure 2.
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480amlodipine, thiazide diuretics, beta-blockers,
ﬁbrates, niacin, statins, and aspirin) before revas-
cularization. This analysis required the exclusion
of individuals who underwent revascularization
before examination 2 (in whom change in medica-
tions was likely a result of revascularization).RESULTS
Clinical characteristics of the study cohort. The
mean age of the study cohort was 62.2  10.2 years,
with slightly more than half women (52.8%). A total
of 265 participants (4.1%) underwent revasculari-
zation, including 206 symptom-driven revascular-
izations (78%), with the majority occurring shortly
after the diagnosis of myocardial infarction or
angina (Fig. 1). Subjects who underwent revascu-
larization were more likely to be male and Cauca-
sian. As expected, the cardiovascular risk proﬁleRevascularization Rate by CAC Score Group and Number of
Arteries With CAC
s a strong, statistically signiﬁcant increase in revascularization with
asing coronary artery calcium (CAC) score group (A) and increasingly
C (B).was less favorable for those requiring revasculariza-
tion compared with those without revascularization
(Table 1). Participants treated with revascularization
had a signiﬁcantly higher median CAC score (254
[IQR: 66 to 741] vs. 0 [IQR: 0 to 70], p < 0.001)
and mean number of vessels with CAC (2.7  1.2
vs. 1.0  1.3, p < 0.001) than those not requiring
revascularization.
CAC and revascularization. The frequency of revas-
cularization increased with increasing CAC score
(CAC score 0, 19 events [0.6%]; CAC score 1 to
100, 64 events [3.8%]; CAC score 101 to 400, 76
events [9.4%]; CAC score >400, 106 events
[19.8%]) and with the total number of vessels with
CAC (0 vessels, 19 [0.6%]; 1 vessel, 25 events
[2.4%]; 2 vessels, 49 events [6.3%]; 3 vessels, 110
events [12.7%]; 4 vessels, 62 events [19.4%]). The
annualized revascularization rates increased accord-
ing to CAC score category from 0.7 events per 1,000
person-years for a CAC score of 0 to 25.4 events per
1,000 person-years for a CAC score>400 (Fig. 2A).
Similarly, the rate of revascularization increased
proportionally to the number of vessels with CACTable 2. Multivariate-Adjusted HRs for Incident Coronary
Revascularization
HR 95% CI p Value
All subjects (n ¼ 6,540)*
CAC group
0 1.0
1–100 4.4 2.6–7.5 <0.001
101–400 9.8 5.8–16.8 <0.001
>400 17.5 10.1–30.3 <0.001
No. of vessels with CAC
0 1.0
1 2.6 1.4–4.8 0.004
2 7.0 4.0–12.3 <0.001
3 12.2 7.2–20.7 <0.001
4 16.8 9.6–29.6 <0.001
Subjects with CAC
scores >0 (n ¼ 3,259)y
No. of vessels with CAC
1 1.0
2 2.5 1.5–4.4 0.001
3 3.4 1.9–6.0 <0.001
4 4.1 2.2–7.7 <0.001
*Model adjusted for age, sex, race or ethnicity, diabetes, smoking, hyper-
tension, low-density lipoprotein cholesterol, high-density lipoprotein choles-
terol, triglycerides, C-reactive protein, family history, antihypertensive
medication use, lipid-lowering medication use, education level, and Multi-
Ethnic Study of Atherosclerosis study site. yModel additionally adjusted for
CAC group (1 to 100, 101 to 400, or >400).
CAC ¼ coronary artery calcium; CI ¼ conﬁdence interval; HR ¼ hazard ratio.
Figure 3. Kaplan-Meier Estimates of Revascularization-Free Survival
Kaplan-Meier estimates of revascularization-free survival by CAC burden (A)
and distribution (B). Log-rank p < 0.001 for both models. CAC ¼ coronary
artery calcium.
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481from an annualized event rate of 0.7 events per
1,000 person-years to 24.8 events per 1,000 person-
years when 4 vessels were involved (Fig. 2B).
Kaplan-Meier estimates of revascularization-free
survival according to CAC score and number of
vessels with CAC are shown in Figures 3A and 3B,
respectively.
Table 2 shows the risk for revascularization
associated with CAC score and number of vessels
with CAC after comprehensive adjustment for car-
diovascular risk factors. The hazard ratio increased
stepwise to >16-fold risk for both CAC score >400
and 4-vessel CAC compared with a CAC score of 0.
CAC distribution remained a signiﬁcant predictor
even after concomitant adjustment for CAC score.
Among those subjects with CAC scores >0,
the number of coronary vessels with CAC remained
a strong, independent predictor of revascularization,
with a more than 4-fold increased risk associated
with 4-vessel CAC compared with CAC in 1 vessel.
Online Tables 1A and 1B repeat these analyses
for individual revascularization types (PCI and
CABG), with similar results for each revasculariza-
tion type.
Mode of revascularization according to CAC
distribution. Among subjects who underwent revas-
cularization, PCI was more common than CABG
(n ¼ 154 vs. n ¼ 111). Figures 4A and 4B compare
the absolute annualized event rates of PCI and
CABGbyCACscore category and number of vessels,
respectively. Rates for both PCI andCABG increased
with higher CAC scores; however, for all CAC
score categories, PCI was more common. In contrast,
when the population was stratiﬁed by number of
vessels with CAC, rates of CABG were higher than
those of PCI among subjects with baseline 4-vessel
CAC.
Figure 5 demonstrates the impact of CAC dis-
tribution on types of revascularization across CAC
score categories (1 to 100, 101 to 400, and >400).
Within all CAC score categories, more diffuse
CAC was associated with an increased proportion of
CABG revascularizations. Among subjects with
CAC scores >400, 4-vessel CAC was associated
with a greater proportion of subjects undergoing
CABG than PCI.
Table 3 demonstrates the speciﬁc characteristics
of CAC distribution according to mode of revas-
cularization. Individuals who underwent CABG in
general had signiﬁcantly higher CAC scores in the
left main, left anterior descending, left circumﬂex,
and right coronary arteries (p < 0.01). Among
participants who underwent CABG, 42% had left
main coronary artery involvement, compared with22% of participants who underwent PCI (p ¼ 0.001).
A total of 74% of subjects who underwent CABG
had 3-vessel CAC, compared with only 51% of
those who underwent PCI (p < 0.001). Just 8% of
all CABG procedures occurred in participants with
no CAC or 1-vessel CAC, whereas these subjects
accounted for 23% of all those treated with PCI
(p < 0.001).
Revascularization among subjects with baseline CAC
scores of 0. Revascularization during a median 8.5
years of follow-up was extremely rare among par-
ticipants with baseline CAC scores of 0 (19 of
3,281 [0.6%]). The median time to revasculariza-
tion for this group was 4.6 years (IQR: 1.7 to 6.0
years). Table 4 shows person-level characteristics of
subjects with baseline CAC scores of 0 who ulti-
mately required revascularization. Fifteen of the 19
participants were classiﬁed as having either angina
or a myocardial infarction within 365 days of
revascularization. Of the 12 participants with
Figure 4.
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482baseline CAC scores of 0 who had repeat MESA
protocol–driven CAC measurements before revas-
cularization, 6 (50%) had developed interim CAC
scores >0.
Sensitivity analyses. The results of the sensitivity
analysis excluding the 2 subjects who underwent
early revascularization within 90 days of CAC
scanning were identical to those of the main analysis
and thus are not shown.
A total of 206 of 265 individuals undergoing
revascularization (78%) were classiﬁed as having
symptom-driven revascularization. Within this
subset, revascularization rates and multivariate-
adjusted risks of revascularization associated with
increasing CAC score and number of vessels with
CAC were similar to the trends noted for the overall
population (Online Figs. 1 and 2, Online Table 2).Rates of CABG and PCI by CAC Burden and Distribution
s a strong, statistically signiﬁcant increase in both percutaneous
intervention (PCI) and coronary artery bypass graft (CABG) with both
coronary artery calcium (CAC) score group (A) and increasing
f coronary arteries with CAC (B).The risk for revascularization associated with
increasing CAC score and number of vessels with
CAC was similar to the primary analysis after
adjustment for change in medication use between
MESA visits 1 and 2 (Online Table 3).
D I SCUSS ION
In this multiethnic cohort of asymptomatic in-
dividuals, we demonstrate that the distribution of
CAC on baseline scans provides incremental risk
information to theAgatston score for predicting need
for future coronary revascularization over 9-year
follow-up. Individuals with baseline CAC scores
>400 or CAC in all 4 coronary vessels had an
approximately 25% risk for revascularization at
8.5-year follow-up, compared with a rate of <1%
among those with zero CAC. Importantly, we
also found that both the total burden and the distri-
bution of CAC were predictive of the mode of
revascularization. A higher CAC burden, more
diffuse distribution of CAC, and left main involve-
ment were all strongly associated with need for
CABG versus PCI. CABG was particularly un-
common among participants with zero CAC or
1-vessel CAC (8%), whereas 74% of 111 total
CABG procedures occurred in subjects with at least
3-vessel CAC at baseline. To our knowledge, this is
the ﬁrst study evaluating the relationship between
CAC distribution and subsequent need for surgical
versus percutaneous revascularization.
Predictors of revascularization. Since Agatston et al.
(15) ﬁrst demonstrated the utility of computed to-
mography in detecting and quantifying CAC, multi-
ple studies have established the value of CAC in
asymptomatic subjects in predicting cardiovascular
events, including myocardial infarction and death
(1–4). The utility of CAC has been shown to extend
across sex and ethnic groups and adds signiﬁcant
improvement in risk reclassiﬁcation when added to
standard risk factors or risk factor scores (2,8,9).
Recently, CAC has been shown to provide superior
discrimination and risk reclassiﬁcation compared with
other common markers of cardiovascular risk when
added to the Framingham risk score or the Reynolds
score (16).
Some prior analyses have included revasculariza-
tion as part of a combined composite cardiovascular
endpoint, but the relationship between CAC
and revascularization has not been independently
evaluated. Although revascularization is often
considered a “soft” endpoint, it accounts for large
health care expenditures, exceeding $28 billion
annually in the United States (17,18), and remains
Figure 5. Proportion of Revascularizations Comparing PCI Versus CABG by
CAC Burden and Distribution
Coronary artery bypass graft (CABG) was more frequent with increasing cor-
onary artery calcium (CAC) score group (A) and with more diffusely distributed
CAC (B,C). CABG became the predominant mode of revascularization when all
coronary arteries were diseased at baseline.
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483an important outcome for both patients and physi-
cians. Furthermore, there is increasing interest in
exploring the additional prognostic utility of
measuring regional or vessel-speciﬁc CAC above
and beyond the total burden of CAC.
Regional measures of CAC distribution and coronary
stenosis. CAC has been shown to correlate with
myocardial perfusion defects (5,19–21), a marker
of ischemia and a surrogate for anatomic stenosis that
is a common indication for revascularization. Schuijf
et al. (21) performed a comparative regional analysis
of CAC scores versus vessel-speciﬁc myocardial
perfusion imaging in 140 patients with clinically sus-
pected coronary artery disease. The mean calcium
score in coronary arteries with normal myocardial
perfusion on single-photon emission computed
tomography was 69  167, whereas a signiﬁcantly
higher calcium score of 272  646 was noted for
coronary arteries with abnormal myocardial perfusion
(p < 0.001).
Furthermore, previous studies have evaluated
the relationship between CAC and angiographic
coronary artery stenosis (12,21). Budoff et al. (22)
previously reported in symptomatic patients that
both increasing CAC burden and number of
vessels with CAC are independently associated
with increased likelihood of angiographically sig-
niﬁcant disease. The reported sensitivity of CAC
to detect signiﬁcant angiographic disease (>50%
stenosis) was 95%, with a speciﬁcity of 44%.
Notably, the speciﬁcity of CAC increased sub-
stantially with increasing number of vessels with
CAC (22).
In addition to total CAC score and number of
vessels with CAC, vessel-speciﬁc CAC score has
been shown to be a robust predictor of angiographic
coronary stenosis (12,23). Qian et al. (23) showed
that lesion-speciﬁc and vessel-speciﬁc CAC scoring
is superior to total Agatston score for the prediction
of obstructive coronary artery disease.
In our study, although we did not directly evaluate
the relationship between CAC and myocardial
perfusion defects or angiographic stenosis, we did
evaluate the association between CAC and revascu-
larization, which is often driven by anatomic stenosis
or ischemia.
Zero CAC score. There has been a tremendous
amount of interest in the potential clinical utility
of a CAC score of 0 (5–7). Blaha et al. (6) studied
more than 44,000 asymptomatic patients referred
for CAC scoring. More than 19,000 had CAC
scores of 0 and had an excellent prognosis, with
estimated 10-year mortality of approximately 1%.
In addition, subjects with CAC scores >10 had
Table 3. CAC Characteristics of Participants Who Underwent Incident
Coronary Revascularization Stratiﬁed by Mode of Revascularization
CAC Distribution
PCI
(n [ 154)
CABG
(n [ 111) p Value
Time from CAC
measurement to
revascularization, yrs
3.6  2.3 4.0  2.4 0.19
By vessel, CAC prevalence
and score
LM 22 42 <0.001
LM CAC score 17.0  63.8 26.8  72.8 0.008*
LAD 86 92 0.12
LAD CAC score 159  210 298  300 <0.001*
LCx 66 86 <0.001
LCx CAC score 95  166 244  382 <0.001*
RCA 66 80 0.009
RCA CAC score 125  300 333  592 <0.001*
Total CAC score, all vessels 396  550 901  1,131 <0.001
Number of vessels 2.4  1.2 3.0  1.1 <0.001
$3-vessel CAC 51 74 <0.001
Values are mean  SD or %. *p values were calculated using nonparametric Kruskal-Wallis
tests.
CABG¼ coronary artery bypass grafting; CAC ¼ coronary artery calcium; LAD ¼ left anterior
descending coronary artery; LCx ¼ left circumﬂex coronary artery; LM ¼ left main coronary
artery; PCI ¼ percutaneous coronary intervention; RCA ¼ right coronary artery.
Table 4. Description of Participants With Baseline CAC Scores of 0 Who Subsequently Req
Age
(yrs) Sex
Race/
Ethnicity Smoking Diabetes HTN
Family
History
of CHD
Time (yrs)
From Baseline
to Most Proximal
CAC Scan
CAC
Repe
Scan
63 Male White Former No Yes Yes 3.5 No
67 Male White Yes No No Yes d d
48 Male Black No No Yes No 4.3 No
57 Male Hispanic Former Yes Yes No 1.8 No
52 Female White Former No No Yes 2.8 Yes
78 Male Black No Yes Yes No d d
46 Male Hispanic Yes No No No 4.8 Yes
56 Female White No No No Yes d d
59 Female Black Former Yes No No d d
68 Female Hispanic No Yes Yes Yes d d
55 Male White Former No No Yes d d
65 Male White Former No Yes No 4.3 Yes
59 Male White Former No Yes Yes 3.3 No
59 Female White Yes No No Yes 1.2 Yes
71 Female White Former No No Yes 3.3 Yes
54 Female Black Former No Yes Yes 1.7 No
51 Male Hispanic Yes Yes Yes Yes 1.5 No
70 Female Black Former No No No d d
65 Male Hispanic No Yes Yes No 4.6 Yes
HTN ¼ hypertension; MI ¼ myocardial infarction; other abbreviations as in Tables 1 and 3.
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484a 4-fold to 8-fold increased risk for dying over
10 years compared with those with CAC scores of
0. The excellent prognosis of a CAC score of 0 in
asymptomatic subjects persists among the elderly,
women, and patients with diabetes and across ethnic
groups (24).
In our present analysis of subjects who were
asymptomatic and free of known cardiovascular
disease at enrollment, we found that the rate of
revascularization during 8.5 years of follow-up was
extraordinarily low among subjects with baseline
CAC scores of 0 (0.7%). Interestingly, 50% of
subjects with baseline CAC scores of 0 who were
rescanned before revascularization had incident
CAC on subsequent protocol-driven CAC scans,
suggesting that measurable interval progression of
coronary atherosclerosis occurred. Progression of
coronary artery calcium has been shown to be
associated with diabetes, metabolic syndrome, and
other traditional risk factors (25,26) and has been
shown to predict total and hard coronary heart
disease events in asymptomatic subjects both with
and without baseline CAC scores > 0 (27).
Study limitations. MESA participants received
limited information about their baseline CAC scansuired Coronary Revascularization
on
at
?
Time of
Revascularization
(yrs) From Baseline
Revascularization
Type
MI or Angina
Before
Revascularization?
4.6 PCI No
1.0 PCI Yes
5.1 PCI Yes
7.4 PCI No
4.9 PCI Yes
3.0 PCI No
6.0 PCI Yes
0.4 PCI Yes
0.3 PCI Yes
1.7 PCI Yes
3.0 PCI Yes
4.8 PCI Yes
7.5 PCI Yes
7.3 CABG Yes
4.3 CABG Yes
5.8 CABG Yes
4.0 CABG Yes
1.5 CABG Yes
7.9 CABG No
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485and were instructed to share these limited results
with their physicians. It is possible that this
knowledge may have inﬂuenced the clinical evalu-
ation, thus potentially biasing the results toward
a stronger relationship between CAC and revas-
cularization. However, in our sensitivity analysis
excluding revascularizations performed within
90 days of CAC scoring, we observed an
equally signiﬁcant relationship between CAC and
revascularization. Furthermore the Kaplan-Meier
estimates show that the majority of revasculariza-
tion events occurred proportionally and remotely.
This suggests that the limited communication
of CAC scores in MESA had little impact on
revascularization.
Alternatively, as a result of the limited knowledge
of the CAC scan results, subjects with elevated
CAC may have had more aggressive risk factor
modiﬁcation, thereby reducing revascularizations
and possibly weakening the relationship between
CAC and revascularization. However, there was no
signiﬁcant difference in the change in use of aspirin
or statins by CAC score groups. Furthermore, when
adjusted for change in medication use, the risk for
revascularization was similar to that in the primary
analysis.
Additionally, revascularization as an outcome
is subject to differences in physician preference
and regional practice and in some cases may have
been done in the absence of symptoms. Further-
more, there was likely a signiﬁcant temporal shiftin the application of PCI during the time of
the study, whereas the indications for CABG
remained largely constant. Despite these concerns,
rates of both PCI and CABG were proportional
during the course of the study and remain
increasingly important outcomes for patients and
physicians.
CONCLUS IONS
In a multiethnic cohort of subjects free of baseline
cardiovascular disease, the overall burden and dis-
tribution of CAC are highly predictive of future
coronary revascularization, including both PCI and
CABG. Among subjects undergoing revasculariza-
tion, more diffuse CAC was predictive of CABG
compared with PCI. Additional research is neces-
sary to further deﬁne whether the anatomic distri-
bution of CAC can add to the risk stratiﬁcation of
other cardiovascular endpoints.
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